Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group
To evaluate the influence of the angiotensin-converting-enzyme inhibitor enalapril (2.5 to 40 mg per day) on the prognosis of severe congestive heart failure (New York Heart Association [NYHA] functional class IV), we randomly assigned 253 patients in a double-blind study to receive either placebo (n = 126) or enalapril (n = 127). Conventional treatment for heart failure, including the use of other vasodilators, was continued in both groups. Follow-up averaged 188 days (range, 1 day to 20 months). The crude mortality at the end of six months (primary end point) was 26 percent in the enalapril group and 44 percent in the placebo group--a reduction of 40 percent (P = 0.002). Mortality was reduced by 31 percent at one year (P = 0.001). By the end of the study, there had been 68 deaths in the placebo group and 50 in the enalapril group--a reduction of 27 percent (P = 0.003). The entire reduction in total mortality was found to be among patients with progressive heart failure (a reduction of 50 percent), whereas no difference was seen in the incidence of sudden cardiac death. A significant improvement in NYHA classification was observed in the enalapril group, together with a reduction in heart size and a reduced requirement for other medication for heart failure. The overall withdrawal rate was similar in both groups, but hypotension requiring withdrawal occurred in seven patients in the enalapril group and in no patients in the placebo group. After the initial dose of enalapril was reduced to 2.5 mg daily in high-risk patients, this side effect was less frequent. We conclude that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms. The beneficial effect on mortality is due to a reduction in death from the progression of heart failure.
This article has been cited by other articles:
Teo, K. K.
(2009). Clinical evidence from ONTARGET: proven cardio- and vascular protection. Eur Heart J Suppl
11: F9-F15
[Abstract][Full Text]
Bohm, M., Mahfoud, F., Werner, C., Teo, K., Baumhakel, M.
(2009). Cardiovascular protection: a breakthrough for high-risk patients. Eur Heart J Suppl
11: F19-F26
[Abstract][Full Text]
Cheong, B. Y.C., Muthupillai, R., Wilson, J. M., Sung, A., Huber, S., Amin, S., Elayda, M. A., Lee, V.-V., Flamm, S. D.
(2009). Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction. Circulation
120: 2069-2076
[Abstract][Full Text]
Slaughter, M. S., Rogers, J. G., Milano, C. A., Russell, S. D., Conte, J. V., Feldman, D., Sun, B., Tatooles, A. J., Delgado, R. M. III, Long, J. W., Wozniak, T. C., Ghumman, W., Farrar, D. J., Frazier, O. H., the HeartMate II Investigators,
(2009). Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device. NEJM
0: NEJMoa0909938v1-1
[Abstract][Full Text]
Zhang, Y., Popovic, Z. B., Bibevski, S., Fakhry, I., Sica, D. A., Van Wagoner, D. R., Mazgalev, T. N.
(2009). Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model. Circ Heart Fail
2: 692-699
[Abstract][Full Text]
Foley, P. W.X., Leyva, F., Frenneaux, M. P.
(2009). What is treatment success in cardiac resynchronization therapy?. Europace
11: v58-v65
[Abstract][Full Text]
Shafiq, M. M., Miller, A. B.
(2009). Blocking aldosterone in heart failure. Ther Adv Cardiovasc Dis
3: 379-385
[Abstract]
Ahmet, I., Morrell, C., Lakatta, E. G., Talan, M. I.
(2009). Therapeutic Efficacy of a Combination of a {beta}1-Adrenoreceptor (AR) Blocker and {beta}2-AR Agonist in a Rat Model of Postmyocardial Infarction Dilated Heart Failure Exceeds That of a {beta}1-AR Blocker plus Angiotensin-Converting Enzyme Inhibitor. J. Pharmacol. Exp. Ther.
331: 178-185
[Abstract][Full Text]
Kwon, D. H., Halley, C. M., Popovic, Z. B., Carrigan, T. P., Zysek, V., Setser, R., Schoenhagen, P., Flamm, S. D., Starling, R. C., Desai, M. Y.
(2009). Gender differences in survival in patients with severe left ventricular dysfunction despite similar extent of myocardial scar measured on cardiac magnetic resonance. Eur J Heart Fail
11: 937-944
[Abstract][Full Text]
Caldwell, J. C., Contractor, H., Petkar, S., Ali, R., Clarke, B., Garratt, C. J., Neyses, L., Mamas, M. A.
(2009). Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace
11: 1295-1300
[Abstract][Full Text]
Patwala, A., Woods, P., Clements, R., Albouaini, K., Rao, A., Goldspink, D., Tan, L.-B., Oo, A., Wright, D.
(2009). A prospective longitudinal evaluation of the benefits of epicardial lead placement for cardiac resynchronization therapy. Europace
11: 1323-1329
[Abstract][Full Text]
Akbari, A., Knoll, G., Ferguson, D., McCormick, B., Davis, A., Biyani, M.
(2009). ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. pdi
29: 554-561
[Abstract][Full Text]
Dzemali, O., Risteski, P., Bakhtiary, F., Singer, E., Zierer, A., Kleine, P., Moritz, A.
(2009). Surgical left ventricular remodeling leads to better long-term survival and exercise tolerance than coronary artery bypass grafting alone in patients with moderate ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg.
138: 663-668
[Abstract][Full Text]
Swedberg, K.
(2009). Fallacies in clinical cardiovascular trials. Heart
95: 1464-1468
[Full Text]
Hsich, E. M., Pina, I. L.
(2009). Heart failure in women: a need for prospective data.. J Am Coll Cardiol
54: 491-498
[Abstract][Full Text]
Ferrari, R.
(2009). Cardiovascular protection by angiotensin-converting enzyme inhibition. Eur Heart J Suppl
11: E1-E3
[Full Text]
Baliga, V., Sapsford, R.
(2009). Review article: Diabetes mellitus and heart failure -- an overview of epidemiology and management. Diabetes and Vascular Disease Research
6: 164-171
[Abstract]
Bansal, S., Lindenfeld, J., Schrier, R. W.
(2009). Sodium Retention in Heart Failure and Cirrhosis: Potential Role of Natriuretic Doses of Mineralocorticoid Antagonist?. Circ Heart Fail
2: 370-376
[Abstract][Full Text]
Mamas, M. A., Caldwell, J. C., Chacko, S., Garratt, C. J., Fath-Ordoubadi, F., Neyses, L.
(2009). A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail
11: 676-683
[Abstract][Full Text]
Hobbs, F D R.
(2009). Delivering quality and value in heart failure. BMJ
338: b1672-b1672
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: 1343-1382
[Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: 1977-2016
[Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: e391-e479
[Full Text]
Calvert, M. J, Shankar, A., McManus, R. J, Ryan, R., Freemantle, N.
(2009). Evaluation of the management of heart failure in primary care. Fam Pract
26: 145-153
[Abstract][Full Text]
Hobbs, F.D.R.
(2009). Clinical burden and health service challenges of chronic heart failure. Eur J Heart Fail Suppl
8: i1-i4
[Full Text]
Swedberg, K.
(2009). Tailoring therapy in chronic heart failure. Eur J Heart Fail Suppl
8: i25-i29
[Full Text]
Cleland, J. G.F., Cullington, D.
(2009). Digoxin: Quo Vadis?. Circ Heart Fail
2: 81-85
[Full Text]
Baumhakel, M., Muller, U., Bohm, M.
(2009). Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail
11: 299-303
[Abstract][Full Text]
Willenheimer, R.
(2009). The current role of beta-blockers in chronic heart failure: with special emphasis on the CIBIS III trial. Eur Heart J Suppl
11: A15-A20
[Abstract][Full Text]
Dunn, S. P., Bleske, B., Dorsch, M., Macaulay, T., Van Tassell, B., Vardeny, O.
(2009). Nutrition and Heart Failure: Impact of Drug Therapies and Management Strategies. Nutr Clin Pract
24: 60-75
[Abstract][Full Text]
van den Borne, S. W.M., Isobe, S., Zandbergen, H. R., Li, P., Petrov, A., Wong, N. D., Fujimoto, S., Fujimoto, A., Lovhaug, D., Smits, J. F.M., Daemen, M. J.A.P., Blankesteijn, W. M., Reutelingsperger, C., Zannad, F., Narula, N., Vannan, M. A., Pitt, B., Hofstra, L., Narula, J.
(2009). Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.. J Am Coll Cardiol Img
2: 187-198
[Abstract][Full Text]
Hollenberg, S. M.
(2009). Heart Failure and Cardiac Pulmonary Edema. ACCP Crit Care Med Brd Rev
20: 117-128
[Full Text]
Dahlstrom, U., Hakansson, J., Swedberg, K., Waldenstrom, A.
(2009). Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden. Eur J Heart Fail
11: 92-98
[Abstract][Full Text]
Orso, F., Baldasseroni, S., Fabbri, G., Gonzini, L., Lucci, D., D'Ambrosi, C., Gobbi, M., Lecchi, G., Randazzo, S., Masotti, G., Tavazzi, L., Maggioni, A. P., on behalf of Italian Survey on Acute Heart Failure,
(2009). Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure. Eur J Heart Fail
11: 77-84
[Abstract][Full Text]
McMurray, J., Petrie, M., Swedberg, K., Komajda, M., Anker, S., Gardner, R.
(2009). CHAPTER 23 Heart Failure. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Curtis, L. H., Greiner, M. A., Hammill, B. G., Kramer, J. M., Whellan, D. J., Schulman, K. A., Hernandez, A. F.
(2008). Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005. Arch Intern Med
168: 2481-2488
[Abstract][Full Text]
Holubarsch, C. J.F., Colucci, W. S., Meinertz, T., Gaus, W., Tendera, M., Survival and Prognosis: Investigation of Crataegus,
(2008). The efficacy and safety of Crataegus extract WS(R) 1442 in patients with heart failure: The SPICE trial. Eur J Heart Fail
10: 1255-1263
[Abstract][Full Text]
Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M.C., Sutton, G. C., McDonagh, T. A., Cowie, M. R.
(2008). Mode of death in patients with newly diagnosed heart failure in the general population. Eur J Heart Fail
10: 1108-1116
[Abstract][Full Text]
Martin, K. A., Hwa, J.
(2008). Shp Shape: FAKs About Hypertrophy. Circ. Res.
103: 776-778
[Full Text]
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., Matthews, D. R.
(2008). Long-Term Follow-up after Tight Control of Blood Pressure in Type 2 Diabetes. NEJM
359: 1565-1576
[Abstract][Full Text]
de Resende, M. M., Amaral, S. L., Moreno, C., Greene, A. S.
(2008). Congenic strains reveal the effect of the renin gene on skeletal muscle angiogenesis induced by electrical stimulation. Physiol. Genomics
33: 33-40
[Abstract][Full Text]
Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F.
(2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J
29: 2388-2442
[Full Text]
Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K.
(2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail
10: 933-989
[Full Text]
Ogihara, T., Rakugi, H.
(2008). Which strategy in inhibition of the renin-angiotensin system is the most efficient for heart failure?. Journal of Renin-Angiotensin-Aldosterone System
9: 184-185
Crespo, M. J., Cruz, N., Altieri, P. I., Escobales, N.
(2008). Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster. J CARDIOVASC PHARMACOL THER
13: 199-206
[Abstract]
Hauptman, P. J.
(2008). All clinical trials are not created equal: The dilemma of HEAAL. Eur J Heart Fail
10: 817-818
[Full Text]
Schindler, C.
(2008). ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET. Ther Adv Cardiovasc Dis
2: 233-248
[Abstract]
Gutierrez, O. M., Tamez, H., Bhan, I., Zazra, J., Tonelli, M., Wolf, M., Januzzi, J. L., Chang, Y., Thadhani, R.
(2008). N-terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Concentrations in Hemodialysis Patients: Prognostic Value of Baseline and Follow-up Measurements. Clin. Chem.
54: 1339-1348
[Abstract][Full Text]
Ootaki, C., Yamashita, M., Ootaki, Y., Kamohara, K., Weber, S., Klatte, R. S., Smith, W. A., Massiello, A. L., Emancipator, S. N., Golding, L. A.R., Fukamachi, K.
(2008). Reduced Pulsatility Induces Periarteritis in Kidney: Role of the Local Renin-Angiotensin System. J. Thorac. Cardiovasc. Surg.
136: 150-158
[Abstract][Full Text]
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., Waldo, A. L., the Atrial Fibrillation and Congestive Heart Failu,
(2008). Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. NEJM
358: 2667-2677
[Abstract][Full Text]
Werner, C. M., Bohm, M.
(2008). Review: The therapeutic role of RAS blockade in chronic heart failure. Ther Adv Cardiovasc Dis
2: 167-177
[Abstract]
Kasama, S., Toyama, T., Sumino, H., Nakazawa, M., Matsumoto, N., Sato, Y., Kumakura, H., Takayama, Y., Ichikawa, S., Suzuki, T., Kurabayashi, M.
(2008). Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. JNM
49: 907-914
[Abstract][Full Text]
Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A.
(2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 776S-814S
[Abstract][Full Text]
Beer, M., Wagner, D., Myers, J., Sandstede, J., Kostler, H., Hahn, D., Neubauer, S., Dubach, P.
(2008). Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy. J Am Coll Cardiol
51: 1883-1891
[Abstract][Full Text]
Eisen, H. J.
(2008). Exercise Training and Myocardial Energetics in Patients With Heart Failure: When More Is Less. J Am Coll Cardiol
51: 1892-1895
[Full Text]
Pilote, L. MD PhD, Abrahamowicz, M. PhD, Eisenberg, M. MD MPH, Humphries, K. DSc, Behlouli, H. MSc PhD, Tu, J. V. MD PhD
(2008). Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure. CMAJ
178: 1303-1311
[Abstract][Full Text]
McMurray, J. J.V., Pitt, B., Latini, R., Maggioni, A. P., Solomon, S. D., Keefe, D. L., Ford, J., Verma, A., Lewsey, J., for the Aliskiren Observation of Heart Failure Tre,
(2008). Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure. Circ Heart Fail
1: 17-24
[Abstract][Full Text]
Anand, I. S., Rector, T. S., Kuskowski, M., Thomas, S., Holwerda, N.J., Cohn, J. N.
(2008). Effect of Baseline and Changes in Systolic Blood Pressure Over Time on the Effectiveness of Valsartan in the Valsartan Heart Failure Trial. Circ Heart Fail
1: 34-42
[Abstract][Full Text]
Katz, A. M.
(2008). The "Modern" View of Heart Failure: How Did We Get Here?. Circ Heart Fail
1: 63-71
[Full Text]
Verjans, J. W.H., Lovhaug, D., Narula, N., Petrov, A. D., Indrevoll, B., Bjurgert, E., Krasieva, T. B., Petersen, L. B., Kindberg, G. M., Solbakken, M., Cuthbertson, A., Vannan, M. A., Reutelingsperger, C. P.M., Tromberg, B. J., Hofstra, L., Narula, J.
(2008). Noninvasive imaging of angiotensin receptors after myocardial infarction.. J Am Coll Cardiol Img
1: 354-362
[Abstract][Full Text]
Tanaka, T., Tsutamoto, T., Sakai, H., Nishiyama, K., Fujii, M., Yamamoto, T., Horie, M.
(2008). Effect of atrial natriuretic peptide on adiponectin in patients with heart failure. Eur J Heart Fail
10: 360-366
[Abstract][Full Text]
Sharma, V., Dhillon, P., Wambolt, R., Parsons, H., Brownsey, R., Allard, M. F., McNeill, J. H.
(2008). Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat. Am. J. Physiol. Heart Circ. Physiol.
294: H1609-H1620
[Abstract][Full Text]
Coffman, T. M., Crowley, S. D.
(2008). Kidney in Hypertension: Guyton Redux. Hypertension
51: 811-816
[Full Text]
Weir, R.A.P., McMurray, J. J.V., Puu, M., Solomon, S. D., Olofsson, B., Granger, C. B., Yusuf, S., Michelson, E. L., Swedberg, K., Pfeffer, M. A., CHARM Investigators,
(2008). Efficacy and tolerability of adding an angiotensin receptor blocker in patients with heart failure already receiving an angiotensin-converting inhibitor plus aldosterone antagonist, with or without a beta blocker. Findings from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial. Eur J Heart Fail
10: 157-163
[Abstract][Full Text]
Brunetti, L., DeSantis, E. R. H.
(2008). Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm
65: 132-137
[Abstract][Full Text]
Patel, N. D., Nwakanma, L. U., Weiss, E. S., Williams, J. A., Conte, J. V.
(2008). Impact of Septal Myocardial Infarction on Outcomes After Surgical Ventricular Restoration. Ann. Thorac. Surg.
85: 135-146
[Abstract][Full Text]
Symeonides, P., Koulouris, S., Vratsista, E., Triantafyllou, K., Ioannidis, G., Thalassinos, N., Katritsis, D.
(2007). Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: A comparative study. Eur J Echocardiogr
8: 480-486
[Abstract][Full Text]
Remme, W. J.
(2007). Filling the gap between guidelines and clinical practice in heart failure treatment -- Still a far cry from reality. Eur J Heart Fail
9: 1143-1145
[Full Text]
de Groote, P., Isnard, R., Assyag, P., Clerson, P., Ducardonnet, A., Galinier, M., Jondeau, G., Leurs, I., Thebaut, J.-F., Komajda, M.
(2007). Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail
9: 1205-1211
[Abstract][Full Text]
Triller, D. M., Hamilton, R. A.
(2007). Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm
64: 2244-2249
[Abstract][Full Text]
Seed, A., Gardner, R., McMurray, J., Hillier, C., Murdoch, D., MacFadyen, R., Bobillier, A., Mann, J., McDonagh, T.
(2007). Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. Eur J Heart Fail
9: 1120-1127
[Abstract][Full Text]
Rodriguez-Granillo, G. A., de Winter, S., Bruining, N., Ligthart, J. M.R., Garcia-Garcia, H. M., Valgimigli, M., de Feyter, P. J., on behalf of the EUROPA/PERSPECTIVE Investigators,
(2007). Effect of perindopril on coronary remodelling: insights from a multicentre, randomized study. Eur Heart J
28: 2326-2331
[Abstract][Full Text]
Kitsios, G., Zintzaras, E.
(2007). Genetic Variation associated with Ischemic Heart Failure: A HuGE Review and Meta-Analysis. Am J Epidemiol
166: 619-633
[Abstract][Full Text]
Saha, S. A., Molnar, J., Arora, R. R.
(2007). Tissue ACE Inhibitors for Secondary Prevention of Cardiovascular Disease in Patients With Preserved Left Ventricular Function: A Pooled Meta-analysis of Randomized Placebo-controlled Trials. J CARDIOVASC PHARMACOL THER
12: 192-204
[Abstract]
Borer, J. S.
(2007). Angiotensin-converting enzyme inhibition: a landmark advance in treatment for cardiovascular diseases. Eur Heart J Suppl
9: E2-E9
[Abstract][Full Text]
Husser, O., Husser, D., Stridh, M., Sornmo, L., Corino, V. D.A., Mainardi, L. T., Lombardi, F., Klein, H. U., Olsson, S. B., Bollmann, A.
(2007). Exercise testing for non-invasive assessment of atrial electrophysiological properties in patients with persistent atrial fibrillation. Europace
9: 627-632
[Abstract][Full Text]
Fonarow, G. C., Abraham, W. T., Albert, N. M., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., Pieper, K., Sun, J. L., Yancy, C. W., Young, J. B., for the OPTIMIZE-HF Investigators and Hospitals,
(2007). Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart Failure: Results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med
167: 1493-1502
[Abstract][Full Text]
Fruhwald, F. M., Fahrleitner-Pammer, A., Berger, R., Leyva, F., Freemantle, N., Erdmann, E., Gras, D., Kappenberger, L., Tavazzi, L., Daubert, J.-C., Cleland, J. G.F.
(2007). Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony. Eur Heart J
28: 1592-1597
[Abstract][Full Text]
Frohlich, E. D.
(2007). The Salt Conundrum: A Hypothesis. Hypertension
50: 161-166
[Full Text]
Patel, J., Heywood, J. T.
(2007). Mode of Death in Patients With Systolic Heart Failure. J CARDIOVASC PHARMACOL THER
12: 127-136
[Abstract]
Patel, N. D., Williams, J. A., Nwakanma, L. U., Weiss, E. S., Conte, J. V.
(2007). Impact of Lateral Wall Myocardial Infarction on Outcomes After Surgical Ventricular Restoration. Ann. Thorac. Surg.
83: 2017-2028
[Abstract][Full Text]
